Glaucoma therapy-related ocular surface disease (OSD) is a serious pathology with a broad
spectrum of insidious clinical presentations and complex pathogenesis that undermines …

The key clinical attributes of preserved dorzolamide/timolol fixed combination (DTFC) and
the emerging potential of preservative-free (PF) DTFC are reviewed with published evidence …

Background Recurrent use of oral corticosteroids (OCS) and over-use of short-acting beta-2-
agonists (SABA) are factors associated with adverse side effects and asthma-related death …

Purpose: The XEN gel stent is a minimally invasive surgical device aimed at creating a
subconjunctival drainage of aqueous humor, thereby reducing intraocular pressure (IOP) …

Background Ciclo plasty using high-intensity focused ultrasound (HIFU) technology acts
through the selective coagulation of the ciliary body. Our aim was to evaluate the safety and …

Purpose: Glaucoma leads as the first cause of irreversible blindness. The number of patients
will greatly increase in upcoming years and changes will have to be accomplished to cope …

Aim High-intensity focused ultrasound cystoplasty (UCP) aims to noninvasively and
selectively target the ciliary body, thus lowering intraocular pressure (IOP). To be used on a …

Background: Different drugs have been approved to reduce the intraocular pressure.
However, most of them contain preservatives to maintain sterility and these can be toxic to …

AIM To determine initial medication adherence in newly diagnosed glaucoma patients
treated with anti-glaucoma drugs. METHODS This retrospective and observational study …

Background: Monotherapy, age, and side effects are significant risk factors for the
discontinuation of antiglaucoma therapy. Long-term therapy persistence is crucial for …